Sveriges mest populära poddar
Biotech 2050 Podcast
Vetenskap

44. Revolutionizing the drug discovery marketplace, Kevin Lustig, Founder and CEO, Scientist.com

24 min•3 februari 2021
Kevin is a scientist-entrepreneur with 30 years of research experience in academia and pharma. He co-founded Scientist.com in 2007. In 2001, he co-founded Kalypsys, a small pharmaceutical company. He was Director of Lead Discovery at Tularik from 1997-2001. He carried out postdoctoral work at Harvard Medical School after receiving a PhD degree from Marc Kirschner’s laboratory at UC-San Francisco and an A.B. degree, magna cum laude, from Cornell University.

Fler avsnitt av Biotech 2050 Podcast

Visa alla avsnitt av Biotech 2050 Podcast
Barry Quart, CEO of Connect Biopharma, on Asthma Innovation & Biotech Leadership
•23 min
Adial CEO Cary Claiborne on Treating Alcohol Addiction with Genetics
•14 min
Sheila Gujrathi, MD on Leadership, Biotech Innovation & The Mirror Effect for Women Leaders
•40 min
Fred Aslan, Artiva CEO, on Cell Therapy’s Next Wave, RA Trials & Scalable NK Platforms
•25 min
Michelle Werner, CEO of Alltrna, on tRNA Platforms, Rare Disease & Drug Innovation
•27 min
Brian Hilberdink on Boehringer’s U.S. Growth, AI & Pharma’s Next Frontier
•22 min
Johan Luthman, Lundbeck EVP R&D, on Rebuilding Neuroscience Pipelines & Drug Discovery
•31 min
Christophe Bourdon, LEO Pharma CEO, on Dermatology Innovation, Rare Disease & Scalable Growth
•13 min
Matt Gline, Roivant Sciences CEO, on Clinical Breakthroughs, Capital Discipline & Building Biotech
•34 min
Jay Hartenbach, President & COO, Diakonos Oncology on Reprogramming Cancer Immunity Breakthrough
•28 min

Biotech 2050 Podcast med Biotech 2050 finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.